The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of trifluridine/tipiracil in combination with gemcitabine (gem) and nab-paclitaxel (nab-P) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC).
 
Anita Ahmed Turk
Consulting or Advisory Role - Exelixis
Research Funding - Lilly (Inst)
 
Paul R. Helft
No Relationships to Disclose
 
Amikar Sehdev
Employment - Ironwood Cancer and Research Centers
Stock and Other Ownership Interests - Pfizer
Honoraria - Aptitude Health; Horizon CME
 
Safi Shahda
Employment - Intellia Therapeutics; Loxo/Lilly
Stock and Other Ownership Interests - Intellia Therapeutics
 
Patrick J. Loehrer
Research Funding - Lilly Foundation (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - US PPA/61/499,988 Gene Expression Analysis of Thymic Neoplasms Inventors: Sunil Badve, Yesim Gokmen-Polar, Patrick Loehrer (Inst)
Other Relationship - National Cancer Institute